Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Pharmacogenetics and Pharmacogenomics: Overview01:29

Pharmacogenetics and Pharmacogenomics: Overview

Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A viral protein promotes host L-asparaginase activity and weakens the asparagine-induced resistance pathway for the benefit of virus infection.

Journal of experimental botany·2026
Same author

Integrative learning of individualized treatment rules from multiple studies with partially overlapping treatments.

Biometrics·2026
Same author

The effect of family capital on critical thinking skills of primary and middle school students in rural county-level regions of China: The chain mediating role of home-school cooperation and teachers' expectations.

Acta psychologica·2026
Same author

Next-Generation Sequencing Analysis of 8-Oxo-7,8-dihydroguanine in Human Mitochondrial DNA.

Chemical research in toxicology·2026
Same author

Assessing the NO and SO<sub>2</sub> pollution impacts on the Δ<sup>3</sup>-carene photooxidation mechanisms.

Environmental pollution (Barking, Essex : 1987)·2026
Same author

Dietary diversity, multidimensional gait characteristics, and related biomarkers in older adults: a wearable sensors study.

The journal of nutrition, health & aging·2026
Same journal

Cerebral organoids and organoid intelligence: ethical challenges and governance pathway.

Frontiers of medicine·2025
Same journal

Immune cells in diabetic wound repair: the key to better wound management.

Frontiers of medicine·2025
Same journal

LMWH prophylaxis in pregnancy outcomes of women with suspected protein S deficiency: a retrospective case-control study.

Frontiers of medicine·2025
Same journal

Roles of different methylation modifications in cardiovascular disease.

Frontiers of medicine·2025
Same journal

Prognostic utility of baseline ASCL1/INSM1 expression and neutrophil-lymphocyte ratio in unresectable SCLC treated with first-line chemoimmunotherapy with or without radiotherapy.

Frontiers of medicine·2025
Same journal

"Zero-distance" photocrosslinking: a paradigm shift in probing DNA-protein dynamics.

Frontiers of medicine·2025
See all related articles

Related Experiment Video

Updated: May 14, 2026

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
07:41

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

Recent development on statistical methods for personalized medicine discovery.

Yingqi Zhao1, Donglin Zeng

  • 1Department of Biostatistics and Medical Informatics, University of Wisconsin-Madison, 600 Highland Ave., Madison, WI 53792, USA.

Frontiers of Medicine
|February 5, 2013
PubMed
Summary
This summary is machine-generated.

Patient responses to treatments vary significantly, necessitating adaptive strategies. New statistical methods help estimate personalized treatment rules from clinical data, though challenges remain.

Related Experiment Videos

Last Updated: May 14, 2026

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
07:41

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

Area of Science:

  • Biostatistics
  • Clinical Trial Design
  • Personalized Medicine

Background:

  • Patient treatment responses are highly heterogeneous.
  • Optimal treatment strategies require adaptation over time and across individuals.
  • Personalized medicine aims to tailor treatments to individual patient characteristics.

Purpose of the Study:

  • To provide an overview of statistical methods for estimating personalized treatment rules.
  • To highlight challenges in applying these methods to clinical data.
  • To inform the development of adaptive treatment strategies.

Main Methods:

  • Review of recently developed statistical methods for personalized treatment rule estimation.
  • Analysis of methods applicable to single-stage and multiple-stage clinical data.
  • Identification of key challenges in the field.

Main Results:

  • A range of statistical techniques are available for estimating personalized treatment rules.
  • These methods address the heterogeneity of patient responses.
  • Challenges exist in the practical application and further development of these techniques.

Conclusions:

  • Statistical methods offer powerful tools for developing personalized treatment strategies.
  • Addressing identified challenges is crucial for advancing personalized medicine.
  • Further research is needed to refine and implement these methods effectively.